Orion Portfolio Solutions LLC purchased a new position in DocuSign, Inc. (NASDAQ:DOCU – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 11,930 shares of the company’s stock, valued at approximately $1,073,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Kestra Investment Management LLC bought a new position in shares of DocuSign during the fourth quarter worth $30,000. Modus Advisors LLC purchased a new position in shares of DocuSign during the fourth quarter valued at about $36,000. First Horizon Advisors Inc. increased its holdings in shares of DocuSign by 102.6% in the fourth quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock worth $36,000 after purchasing an additional 201 shares during the last quarter. Avion Wealth lifted its position in shares of DocuSign by 309.2% in the fourth quarter. Avion Wealth now owns 487 shares of the company’s stock worth $43,000 after buying an additional 368 shares in the last quarter. Finally, Avior Wealth Management LLC boosted its stake in DocuSign by 36.5% during the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after buying an additional 145 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.
DocuSign Price Performance
DocuSign stock opened at $72.21 on Friday. The stock has a market cap of $14.62 billion, a price-to-earnings ratio of 14.89, a price-to-earnings-growth ratio of 6.94 and a beta of 1.20. The firm has a 50-day moving average of $86.02 and a two-hundred day moving average of $82.17. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on DOCU shares. Citigroup upped their price objective on DocuSign from $113.00 to $115.00 and gave the stock a “buy” rating in a report on Friday, March 14th. Jefferies Financial Group lowered their price objective on shares of DocuSign from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Monday, March 31st. Wells Fargo & Company boosted their target price on shares of DocuSign from $70.00 to $73.00 and gave the stock an “underweight” rating in a report on Friday, March 14th. Bank of America lowered their price target on shares of DocuSign from $112.00 to $98.00 and set a “neutral” rating for the company in a report on Friday, March 14th. Finally, Robert W. Baird set a $93.00 price objective on DocuSign in a research note on Friday, March 14th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, DocuSign presently has a consensus rating of “Hold” and an average target price of $95.83.
View Our Latest Analysis on DocuSign
Insider Transactions at DocuSign
In other news, Director Peter Solvik sold 10,000 shares of DocuSign stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $91.26, for a total value of $912,600.00. Following the transaction, the director now owns 150,253 shares of the company’s stock, valued at $13,712,088.78. The trade was a 6.24 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider James P. Shaughnessy sold 7,500 shares of the stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total transaction of $609,825.00. Following the sale, the insider now directly owns 45,875 shares of the company’s stock, valued at $3,730,096.25. The trade was a 14.05 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 57,851 shares of company stock valued at $4,911,319. Corporate insiders own 1.66% of the company’s stock.
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
- Five stocks we like better than DocuSign
- How to Find Undervalued Stocks
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- 3 Healthcare Dividend Stocks to Buy
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Manufacturing Stocks Investing
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.